Cynthia X. Ma, MD, Professor, Department of Medicine, Oncology Division of Medial Oncology of Washington University School of Medicine. In this video, she speaks about the ASCO 2022 Abstract – FLEX, the 30,000 breast cancer transcriptome project: A platform for early breast cancer research using full-genome arrays paired with clinical data.
Synopsis:
The FLEX Registry will be set up as a large-scale, population-based prospective registry. All patients with stage I to III breast cancer who obtain MammaPrint® and BluePrint testing on a primary breast tumor are eligible to join the FLEX Registry, which is designed to allow for additional study arms with minimal additional work and cost. The FLEX Registry will have an adaptive design, which allows for the addition of additional targeted substudies and arms after the original research is launched.